Pharsight

Drugs that contain Docosanol

1. Abreva patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5534554 HALEON US HOLDINGS Sucrose ester-C20 to C28 alcohol formulations
Dec, 2013

(10 years ago)

US4874794 HALEON US HOLDINGS Inflammatory disease treatment
Apr, 2014

(10 years ago)

Market Authorisation Date: 25 July, 2000

Treatment: Treats cold sores/fever blisters on the face or lips. shortens healing time and duration of symptoms: tingling, pain, burning and/or itching

Dosage: CREAM;TOPICAL

More Information on Dosage

ABREVA family patents

Family Patents